Showing results (271-280 of 319) with videos related to
Sort By:
Pageof 32
The Oncologist|March 31, 2025
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2Cathy Eng, Arvind Dasari, Sara Lonardi, et al.Plos One|March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2022
Anal Cancer: Emerging Standards in a Rare DiseaseCathy Eng, Kristen K Ciombor, May Cho, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2017
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal CancerChristine M Parseghian, Nila U Parikh, Ji Yuan Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancerAlberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAActSheela Rao, Francesco Sclafani, Cathy Eng, et al.Cancer|November 23, 2017
Physician interpretation of genomic test results and treatment selectionLauren L Brusco, Chetna Wathoo, Kenna R Mills Shaw, et al.Advances in Radiation Oncology|November 9, 2017
Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysisJillian R Gunther, Awalpreet S Chadha, Ui Sup Shin, et al.JAMA Network Open|June 1, 2023
Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover TrialJohn Paul Shen, Abdelrahman M Yousef, Fadl A Zeineddine, et al.Pageof 32